Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
International Journal of Urology : Official Journal of the Japanese Urological Association|August 22, 2012
Interpreting a rising prostate-specific antigen after brachytherapy for prostate cancerMiren Gaztañaga, Juanita CrookJournal of the National Comprehensive Cancer Network : JNCCN|September 8, 2012
Androgen deprivation therapy: minimizing exposure and mitigating side effectsMiren Gaztañaga, Juanita CrookBrachytherapy|July 4, 2012
Permanent seed brachytherapy for locally recurrent prostate cancer after radical prostatectomy: a case report and review of the literatureMiren Gaztañaga, Juanita Mary CrookBrachytherapy|October 2, 2013
Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planningDeidre Batchelar, Miren Gaztañaga, Matt Schmid, et al.Brachytherapy|June 21, 2011
Long-term results of 1-week intravaginal high-dose-rate brachytherapy alone for endometrial cancerMiren Gaztañaga, Mauricio Cambeiro, Elena Villafranca, et al.International Journal of Radiation Oncology, Biology, Physics|March 1, 2011
Interaction of 2-Gy equivalent dose and margin status in perioperative high-dose-rate brachytherapyRafael Martínez-Monge, Mauricio Cambeiro, Marta Moreno, et al.International Journal of Radiation Oncology, Biology, Physics|May 31, 2011
Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB)Rafael Martínez-Monge, María Pagola Divassón, Mauricio Cambeiro, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 5, 2010
A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancerRafael Martínez-Monge, Miren Gaztañaga, José Manuel Aramendía, et al.Head & Neck|January 24, 2012
Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancerMiren Gaztañaga, María Pagola, Mauricio Cambeiro, et al.Brachytherapy|July 15, 2026
Long-term outcomes of real-time TRUS-guided HDR brachytherapy monotherapy for low and favorable intermediate-risk prostate cancer and predictive value of PSA nadirMiren Gaztañaga, Carmen Escribano, Beatriz Montero, et al.Pageof 3